Free Trial
NASDAQ:MLAB

Mesa Laboratories (MLAB) Stock Price, News & Analysis

$111.64
-1.16 (-1.03%)
(As of 05/24/2024 ET)
Today's Range
$108.00
$117.16
50-Day Range
$99.40
$122.22
52-Week Range
$82.86
$150.30
Volume
35,295 shs
Average Volume
29,974 shs
Market Capitalization
$601.74 million
P/E Ratio
656.74
Dividend Yield
0.57%
Price Target
$130.00

Mesa Laboratories MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
16.4% Upside
$130.00 Price Target
Short Interest
Healthy
2.78% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
0.12mentions of Mesa Laboratories in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
16.91%
From $6.15 to $7.19 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.73 out of 5 stars

Medical Sector

461st out of 917 stocks

Process Control Instruments Industry

9th out of 12 stocks

MLAB stock logo

About Mesa Laboratories Stock (NASDAQ:MLAB)

Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally. It operates in four segments: Clinical Genomics, Sterilization and Disinfection Control, Biopharmaceutical Development, and Calibration Solutions. The Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in various therapeutic areas, such as screenings for hereditary diseases, pharmacogenetics, and oncology related applications. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. The Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enable customers to automate chemical synthesis of peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The Calibration Solutions segment designs, manufactures, and markets quality control products to measure or calibrate temperature, pressure, pH, and humidity for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.

MLAB Stock Price History

MLAB Stock News Headlines

Mesa Laboratories (MLAB) Set to Announce Earnings on Friday
MESA LABS DECLARES QUARTERLY DIVIDEND
Mesa Laboratories Inc.
Here's what Wall Street expects from Mesa Laboratories's earnings
Mesa Labs (MLAB) Lags Q3 Earnings and Revenue Estimates
Earnings Preview: Mesa Laboratories
Andvari Associates Q4 2023 Letter
See More Headlines
Receive MLAB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mesa Laboratories and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/31/2021
Ex-Dividend for 3/15 Dividend
2/28/2024
Dividend Payable
3/15/2024
Today
5/25/2024
Ex-Dividend for 6/14 Dividend
5/31/2024
Next Earnings (Confirmed)
5/31/2024
Dividend Payable
6/14/2024
Fiscal Year End
3/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Process control instruments
Sub-Industry
Electronic Equipment & Instruments
Current Symbol
NASDAQ:MLAB
CUSIP
59064R10
Employees
698
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$130.00
High Stock Price Target
$130.00
Low Stock Price Target
$130.00
Potential Upside/Downside
+16.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$930,000.00
Pretax Margin
-0.28%

Debt

Sales & Book Value

Annual Sales
$219.08 million
Cash Flow
$11.60 per share
Book Value
$73.60 per share

Miscellaneous

Free Float
5,114,000
Market Cap
$601.74 million
Optionable
Not Optionable
Beta
0.82
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

MLAB Stock Analysis - Frequently Asked Questions

Should I buy or sell Mesa Laboratories stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Mesa Laboratories in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" MLAB shares.
View MLAB analyst ratings
or view top-rated stocks.

What is Mesa Laboratories' stock price target for 2024?

1 analysts have issued twelve-month price objectives for Mesa Laboratories' stock. Their MLAB share price targets range from $130.00 to $130.00. On average, they anticipate the company's share price to reach $130.00 in the next year. This suggests a possible upside of 16.4% from the stock's current price.
View analysts price targets for MLAB
or view top-rated stocks among Wall Street analysts.

How have MLAB shares performed in 2024?

Mesa Laboratories' stock was trading at $104.77 on January 1st, 2024. Since then, MLAB shares have increased by 6.6% and is now trading at $111.64.
View the best growth stocks for 2024 here
.

When is Mesa Laboratories' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, May 31st 2024.
View our MLAB earnings forecast
.

How were Mesa Laboratories' earnings last quarter?

Mesa Laboratories, Inc. (NASDAQ:MLAB) announced its earnings results on Monday, May, 31st. The medical instruments supplier reported $0.74 earnings per share for the quarter, missing analysts' consensus estimates of $0.91 by $0.17. The medical instruments supplier earned $37.96 million during the quarter, compared to the consensus estimate of $34.92 million. Mesa Laboratories had a trailing twelve-month return on equity of 7.41% and a net margin of 0.45%.

How often does Mesa Laboratories pay dividends? What is the dividend yield for Mesa Laboratories?

Mesa Laboratories declared a quarterly dividend on Tuesday, April 2nd. Investors of record on Friday, May 31st will be paid a dividend of $0.16 per share on Friday, June 14th. This represents a $0.64 dividend on an annualized basis and a yield of 0.57%. The ex-dividend date is Friday, May 31st.
Read our dividend analysis for MLAB
.

Is Mesa Laboratories a good dividend stock?

Mesa Laboratories (NASDAQ:MLAB) pays an annual dividend of $0.64 per share and currently has a dividend yield of 0.57%. The dividend payout ratio is 376.49%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MLAB will have a dividend payout ratio of 8.90% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MLAB.

What ETFs hold Mesa Laboratories' stock?

ETFs with the largest weight of Mesa Laboratories (NASDAQ:MLAB) stock in their portfolio include Motley Fool Small-Cap Growth ETF (TMFS) and MFAM Small-Cap Growth ETF (MFMS).Zacks Small/Mid Cap Core Portfolio ETF (SMIZ).

What is Gary Owens' approval rating as Mesa Laboratories' CEO?

5 employees have rated Mesa Laboratories Chief Executive Officer Gary Owens on Glassdoor.com. Gary Owens has an approval rating of 51% among the company's employees. This puts Gary Owens in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Mesa Laboratories own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Mesa Laboratories investors own include NVIDIA (NVDA), Verizon Communications (VZ), Intel (INTC), Alibaba Group (BABA), Altria Group (MO), Micron Technology (MU), Exxon Mobil (XOM), AbbVie (ABBV), Advanced Micro Devices (AMD) and Becton, Dickinson and Company (BDX).

Who are Mesa Laboratories' major shareholders?

Mesa Laboratories' stock is owned by many different retail and institutional investors. Top institutional shareholders include Conestoga Capital Advisors LLC (10.77%), Vanguard Group Inc. (6.92%), Geneva Capital Management LLC (3.61%), Raymond James & Associates (1.38%), Motley Fool Asset Management LLC (1.20%) and Kennedy Capital Management LLC (1.11%). Insiders that own company stock include Brian David Archbold, David M Kelly, Evan Guillemin, Gary M Owens, Gregory Dinoia, John Bradley Schmieder, John James Sullivan, John Sakys and Shannon Hall.
View institutional ownership trends
.

How do I buy shares of Mesa Laboratories?

Shares of MLAB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:MLAB) was last updated on 5/25/2024 by MarketBeat.com Staff

From Our Partners